Role of Anti-B-Cell Maturation Antigen (BCMA) in the Management of Multiple Myeloma

SIMPLE SUMMARY: Multiple myeloma is the most prevalent hematological cancer, and further treatments for this disease are required. Despite progress in the development of treatment regimens, multiple myeloma is still an incurable disease because of its poor response to therapy and high rate of resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinaldi, Ikhwan, Muthalib, Abdul, Edina, Brenda Cristie, Wiyono, Lowilius, Winston, Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317279/
https://www.ncbi.nlm.nih.gov/pubmed/35884566
http://dx.doi.org/10.3390/cancers14143507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317279/
https://www.ncbi.nlm.nih.gov/pubmed/35884566
http://dx.doi.org/10.3390/cancers14143507

Ejemplares similares